Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoCloud-9 with Albumin-bound Paclitaxel and Carboplatin in Recurrent Glioblastoma
NCT04528680Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Oct 2020
- Primary completion
- Dec 2027
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in glioblastoma (GBM), sponsored by Northwestern University. Started Oct 2020; status: active, not recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04528680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528680.